FarmaKology Newsletter - Issue #3
www.farmakology.com
FarmaKology Newsletter - Issue #3
News
Lilly and ImmuNext Announce Licensing and Research Collaboration
Eli Lilly and ImmuNext, a developer of immunotherapy compounds for cancer and autoimmune diseases, announced a global licensing and research collaboration worth up to $605 million focused on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases by regulating immune cell metabolism.
FDA Says Breast Density Must Be Reported to Women During Mammograms
Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.
Creative Biostructure Unveils Virus Like Particles to Promote The Research in Drug and Antibody Discovery and Characterization
Transgene, BioInvent extend collaboration to develop multifunctional oncolytic viruses for solid tumors
Investors are starting to bet big on psychedelic medicine
Research
Glowing tumors show scientists where cancer drugs are working
Aspirin to fight an expensive global killer infection
Podcast
Job Opportunities
Pharmacist - Member Support
PHARMACIST- HOSPITAL
PT Weekend Pharmacist
Pharmacist - Floater
Video
